| Literature DB >> 21633509 |
Mazen Salloum1, Nathalie van der Mee-Marquet, Anne-Sophie Valentin-Domelier, Roland Quentin.
Abstract
The phylogenetic position and prophage DNA content of the genomes of 142 S. agalactiae (group-B streptococcus, GBS) isolates responsible for bacteremia and meningitis in adults and neonates were studied and compared. The distribution of the invasive isolates between the various serotypes, sequence types (STs) and clonal complexes (CCs) differed significantly between adult and neonatal isolates. Use of the neighbor-net algorithm with the PHI test revealed evidence for recombination in the population studied (PHI, P = 2.01 × 10(-6)), and the recombination-mutation ratio (R/M) was 6:7. Nevertheless, the estimated R/M ratio differed between CCs. Analysis of the prophage DNA regions of the genomes of the isolates assigned 90% of the isolates to five major prophage DNA groups: A to E. The mean number of prophage DNA fragments amplified per isolate varied from 2.6 for the isolates of prophage DNA group E to 4.0 for the isolates of prophage DNA group C. The isolates from adults and neonates with invasive diseases were distributed differently between the various prophage DNA groups (P < 0.00001). Group C prophage DNA fragments were found in 52% of adult invasive isolates, whereas 74% of neonatal invasive isolates had prophage DNA fragments of groups A and B. Differences in prophage DNA content were also found between serotypes, STs and CCs (P < 0.00001). All the ST-1 and CC1 isolates, mostly of serotype V, belonged to the prophage DNA group C, whereas 84% of the ST-17 and CC17 isolates, all of serotype III, belonged to prophage DNA groups A and B. These data indicate that the transduction mechanisms, i.e., gene transfer from one bacterium to another by a bacteriophage, underlying genetic recombination in S. agalactiae species, are specific to each intraspecies lineage and population of strains responsible for invasive diseases in adults and neonates.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21633509 PMCID: PMC3102099 DOI: 10.1371/journal.pone.0020256
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
PCR primers and amplicon sizes for prophage screening.
| Prophage DNA fragment | Target gene description | Reference strain(s) | PCR primer | Amplicon size (bp) | |
| Orientation | sequence (5′→3′) | ||||
| F5 | A terminase large subunit |
| ForwardReverse |
| 341 |
| F7 | A phage-associated cell wall hydrolase and a phage-associated lysin |
| ForwardReverse |
| 497 |
| F10 | A phage-encoded transcriptional regulator, ArpU family |
| ForwardReverse |
| 510 |
| SAG0566 | Single-strand binding protein prophage lambda Sa1 |
| ForwardReverse |
| 132 |
| SAK_0738 | DNA methylaseprophage lambda W4 | CJB111A909 | ForwardReverse |
| 172 |
| SAK_0748 | Phage major capsid protein HK97 family | CJB111A909 | ForwardReverse |
| 136 |
| SAK_2090 | BRO domain protein, prophage antirepressorprophage Sa05 | A909H36BCJB111 | ForwardReverse |
| 102 |
| SAK_2094 | Prophage Sa05site-specific recombinasephage integrase family | A909H36BCJB11118RS21COH1 | ForwardReverse |
| 526 |
| SAJ_2395 | Phage terminase-like protein, large subunit (remnant) | 18RS21515 | ForwardReverse |
| 251 |
| SAK_1326 | Site-specific recombinase, phage integrase family (remnant) | A909H36BCJB111 | ForwardReverse |
| 261 |
Serotypes of S. agalactiae isolates from blood cultures and CSF from adults and neonates.
| Serotype | No. of | |||||
| Adult | Neonate | |||||
| Blood culture | CSF | Total | Blood culture | CSF | Total | |
| Ia | 15 (22) | 2 (25) | 17 (23) | 4 (20) | 4 (9) | 8 (12) |
| Ib | 12 (18) | 2 (25) | 14 (19) | - | 3 (6) | 3 (4) |
| II | 4 (6) | - | 4 (5) | - | - | - |
| III | 12 (18) | 2 (25) | 14 (19) | 15 (75) | 38 (81) | 53 (79) |
| IV | 2 (3) | - | 2 (3) | - | - | - |
| V | 21 (31) | 2 (25) | 23 (31) | 1 (5) | 2 (4) | 3 (4) |
| NT | 1 (1) | - | 1 (1) | - | - | - |
| Total | 67 | 8 | 75 | 20 | 47 | 67 |
NT, Nontypable.
Figure 1Genetic diversity and sequence type (ST) distribution, determined by MLST [, of 142 S. agalactiae isolates from cases of adult (AI) and neonatal (NI) invasive disease.
We show the phylogenetic network applied to 43 parsimonious-informative sites from a total of 3,456 nucleotides generated with the neighbour-net algorithm for the 142 strains studied (http://splitstree.org/) [29]. Strains were grouped into clonal complexes (CCs) with eBURST software (http://eburst.mlst.net/). Columns indicate the percentages of AI and NI strains in each CC. Recombination (R) and mutation (M) rates, based on MLST data, were evaluated as described by Feil et al. [31]. The estimated recombination-mutation ratio (R/M) varied as a function of the CC to which the strain belonged.
Serotype of S. agalactiae isolates from the various STs and CCs implicated in adult and neonatal invasive infections.
| CC | ST | No. (%) of isolates according to serotype | ||||||
| (No. of isolates) | (No. of isolates) | Ia | Ib | II | III | IV | V | NT |
| 1 (28) | 1 (25) | 2 (100) | 25 (96) | |||||
| 1 (22) | 1 (25) | 21 (81) | ||||||
| 2 (1) | 1 (4) | |||||||
| 153 (1) | 1 (4) | |||||||
| 173 (1) | 1 (4) | |||||||
| 196 (2) | 2 (100) | |||||||
| 383 (1) | 1 (4) | |||||||
| 7 (5) | 2 (8) | 2 (12) | 1 (1) | |||||
| 6 (1) | 1 (6) | |||||||
| 7 (2) | 1 (4) | 1 (1) | ||||||
| 51 (1) | 1 (4) | |||||||
| 255 (1) | 1 (6) | |||||||
| 8 (18) | 15 (88) | 2 (50) | 1 (4) | |||||
| 8 (8) | 8 (47) | |||||||
| 10 (5) | 3 (18) | 1 (25) | 1 (4) | |||||
| 12 (5) | 4 (24) | 1 (25) | ||||||
| 17 (51) | 51 (76) | |||||||
| 17 (49) | 49 (73) | |||||||
| 384 (1) | 1 (1) | |||||||
| 482 (1) | 1 (1) | |||||||
| 19 (11) | 10 (15) | 1 (100) | ||||||
| 19 (10) | 9 (13) | 1 (100) | ||||||
| 382 (1) | 1 (1) | |||||||
| 23 (24) | 21 (84) | 3 (4) | ||||||
| 23 (22) | 20 (80) | 2 (3) | ||||||
| 385 (1) | 1 (4) | |||||||
| 481 (1) | 1 (1) | |||||||
| Singletons (5) | 2 (8) | 1 (25) | 2 (3) | |||||
| 4 (1) | 1 (4) | |||||||
| 22 (2) | 2 (3) | |||||||
| 24 (1) | 1 (4) | |||||||
| 386 (1) | 1 (25) | |||||||
| Total | 25 | 17 | 4 | 67 | 2 | 26 | 1 | |
NT, nontypable.
CC, ST of S. agalactiae isolates from adult and neonatal invasive infections.
| CC | ST | No. (%) of isolates from | |||||
| (No. of isolates) | (No. of isolates) | Adult | Neonate | ||||
| Blood culture | CSF | Total | Blood culture | CSF | Total | ||
| 1 (28) | 23 (34) | 2 (25) | 25 (33) | 1 (5) | 2 (4) | 3 (4) | |
| 1 (22) | 18 (27) | 1 (13) | 19 (25) | 1 (5) | 2 (4) | 3 (4) | |
| 2 (1) | 1 (13) | 1 (1) | |||||
| 153 (1) | 1 (1) | 1 (1) | |||||
| 173 (1) | 1 (1) | 1 (1) | |||||
| 196 (2) | 2 (3) | 2 (3) | |||||
| 383 (1) | 1 (1) | 1 (1) | |||||
| 7 (5) | 3 (4) | 3 (4) | 2 (4) | 2 (3) | |||
| 6 (1) | 1 (2) | 1 (1) | |||||
| 7 (2) | 1 (1) | 1 (1) | 1 (2) | 1 (1) | |||
| 51 (1) | 1 (1) | 1 (1) | |||||
| 255 (1) | 1 (1) | 1 (1) | |||||
| 8 (18) | 14 (21) | 2 (25) | 16 (21) | 2 (4) | 2 (3) | ||
| 8 (8) | 6 (9) | 6 (8) | 2 (4) | 2 (3) | |||
| 10 (5) | 4 (6) | 1 (13) | 5 (7) | ||||
| 12 (5) | 4 (6) | 1 (13) | 5 (7) | ||||
| 17 (51) | 5 (7) | 1 (13) | 6 (8) | 13 (65) | 32 (68) | 45 (67) | |
| 17 (49) | 4 (6) | 1 (13) | 5 (7) | 12 (60) | 32 (68) | 44 (66) | |
| 384 (1) | 1 (1) | 1 (1) | |||||
| 482 (1) | 1 (5) | 1 (1) | |||||
| 19 (11) | 6 (9) | 1 (13) | 7 (9) | 4 (9) | 4 (6) | ||
| 19 (10) | 5 (7) | 1 (13) | 6 (8) | 4 (9) | 4 (6) | ||
| 382 (1) | 1 (1) | 1 (1) | |||||
| 23 (24) | 13 (19) | 2 (25) | 15 (20) | 5 (25) | 4 (9) | 9 (13) | |
| 23 (22) | 12 (18) | 2 (25) | 14 (19) | 4 (20) | 4 (9) | 8 (12) | |
| 385 (1) | 1 (1) | 1 (1) | |||||
| 481 (1) | 1 (5) | 1 (1) | |||||
| Singletons (5) | 3 (4) | 3 (4) | 1 (5) | 1 (2) | 2 (3) | ||
| 4 (1) | 1 (1) | 1 (1) | |||||
| 22 (2) | 1 (1) | 1 (1) | 1 (5) | 1 (1) | |||
| 24 (1) | 1 (2) | 1 (1) | |||||
| 386 (1) | 1 (1) | 1 (1) | |||||
| Total | 67 | 8 | 75 | 20 | 47 | 67 | |
Distribution of the SLVs of the major clonal complexes as a function of difference in the number of nucleotides (one or more) with respect to the sequence of the founder sequence type.
| Clonal complex | Allelic profile MLST | No. of SLVs differing at a single-nucleotide site | No. of SLVs differing at multiple-nucleotide sites | |||||||||
| ST | adhP | pheS | atr | glnA | sdhA | glck | tkt | Different | Shared | Different | Shared | |
| CC1 | ||||||||||||
| Founder ST | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | ||||
| SLV | 2 | 1 | 1 | 3 | 1 | 1 | 2 | 2 | 0 | 1 | 0 | 0 |
| 153 | 36 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 0 | 0 | |
| 173 | 38 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 0 | 0 | 0 | |
| 383 | 1 | 1 | 2 | 42 | 1 | 2 | 2 | 0 | 1 | 0 | 0 | |
| Sub-totals | 2 | 2 | 0 | 0 | ||||||||
| CC7 | ||||||||||||
| Founder ST | 7 | 10 | 1 | 2 | 1 | 3 | 2 | 2 | ||||
| SLV | 6 | 9 | 1 | 2 | 1 | 3 | 2 | 2 | 0 | 1 | 0 | 0 |
| 51 | 10 | 1 | 3 | 1 | 3 | 2 | 2 | 0 | 1 | 0 | 0 | |
| Sub-totals | 0 | 2 | 0 | 0 | ||||||||
| CC8 | ||||||||||||
| Founder ST | 8 | 4 | 1 | 4 | 1 | 3 | 3 | 2 | ||||
| SLV | 10 | 9 | 1 | 4 | 1 | 3 | 3 | 2 | 0 | 1 | 0 | 0 |
| 12 | 10 | 1 | 4 | 1 | 3 | 3 | 2 | 0 | 0 | 0 | 1 | |
| Sub-totals | 0 | 1 | 0 | 1 | ||||||||
| CC17 | ||||||||||||
| Founder ST | 17 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | ||||
| SLV | 384 | 2 | 1 | 1 | 2 | 1 | 37 | 1 | 1 | 0 | 0 | 0 |
| 482 | 2 | 1 | 1 | 2 | 47 | 1 | 1 | 1 | 0 | 0 | 0 | |
| Sub-totals | 2 | 0 | 0 | 0 | ||||||||
| CC19 | ||||||||||||
| Founder ST | 19 | 1 | 1 | 3 | 2 | 2 | 2 | 2 | ||||
| SLV | 382 | 72 | 1 | 3 | 2 | 2 | 2 | 2 | 1 | 0 | 0 | 0 |
| Sub-totals | 1 | 0 | 0 | 0 | ||||||||
| CC23 | ||||||||||||
| Founder ST | 23 | 5 | 4 | 6 | 3 | 2 | 1 | 3 | ||||
| SLV | 385 | 5 | 4 | 6 | 3 | 2 | 1 | 30 | 1 | 0 | 0 | 0 |
| 481 | 5 | 4 | 6 | 51 | 2 | 1 | 3 | 1 | 0 | 0 | 0 | |
| Sub-totals | 2 | 0 | 0 | 0 | ||||||||
| totals | 7 | 5 | 0 | 1 | ||||||||
Figure 2Distribution of 141 S. agalactiae isolates from adult (ACSF and AB) and neonatal (NCFS and NB) patients with invasive disease between prophage DNA groups, on the basis of PCR evaluations of the prophage content of isolates.
Jaccard analysis generated a dendrogram of similarity values for the 10 prophage sequences described in table 1 (SYSTAT 12 software). Five major prophage DNA groups were defined (groups A to E). The mean number of prophage DNA fragments amplified from strains by PCR and the mean number of absolute deviations (Avedev) were calculated for each prophage DNA group. a anatomic origin of isolates; b serotype of isolates; ST, sequence-type; CC, clonal complex; NT, nontypeable.
Distribution of the S. agalactiae isolates of various origins, serotypes, sequence types, and clonal complexes between prophage DNA groups, as displayed by SYSTAT 12 softwarea.
| Characteristic(No. of strains) | No. of strains (%) per prophage DNA group | ||||||
| NP | A (35) | B (30) | C (45) | D (9) | E (8) | minor groups (14) | |
| Prophage DNA fragment | |||||||
| F5 | 109 (77) | 21 (15) | 2 (1) | 6 (4) | 2 (1) | 2 (1) | |
| F7 | 101 (71) | 26 (18) | 7 (5) | 2 (1) | 2 (1) | 1 (<1) | 3 (2) |
| F10 | 96 (68) | 28 (20) | 2 (1) | 8 (6) | 2 (1) | 4 (3) | 2 (1) |
| SAG0566 | 140 (99) | 1 (<1) | 1 (<1) | ||||
| SAK_0738 | 109 (77) | 32 (23) | 1 (<1) | ||||
| SAK_0748 | 40 (28) | 18 (13) | 29 (20) | 45 (32) | 8 (6) | 2 (1) | |
| SAK_2090 | 29 (20) | 29 (20) | 29 (20) | 45 (32) | 9 (6) | 1 (<1) | |
| SAK_2094 | 113 (80) | 7 (5) | 15 (11) | 2 (1) | 1 (<1) | 4 (3) | |
| SAJ_2395 | 138 (97) | 2 (1) | 2 (1) | ||||
| SAK_1326 | 74 (52) | 4 (3) | 2 (1) | 41 (29) | 9 (6) | 6 (4) | 6 (4) |
| Origin | |||||||
| Adult blood culture (67) | 9 (13) | 5 (7) | 35 (52) | 5 (7) | 6 (9) | 7 (10) | |
| Adult CSF (8) | 1 (13) | 1 (13) | 4 (50) | 1 (13) | 1 (13) | ||
| Adult (75) | 1 (1) | 10 (13) | 5 (7) | 39 (52) | 5 (7) | 7 (9) | 8 (11) |
| Neonatal blood culture (20) | 7 (35) | 7 (35) | 2 (10) | 2 (10) | 1 (5) | 1 (5) | |
| Neonatal CSF (47) | 18 (38) | 18 (38) | 4 (9) | 2 (4) | 5 (11) | ||
| Neonate (67) | 25 (37) | 25 (37) | 6 (9) | 4 (6) | 1 (1) | 6 (9) | |
| Serotype | |||||||
| Ia (25) | 3 (12) | 9 (36) | 5 (20) | 5 (20) | 3 (12) | ||
| Ib (17) | 1 (6) | 2 (12) | 6 (35) | 3 (18) | 1 (6) | 4 (24) | |
| II (4) | 1 (25) | 2 (50) | 1 (25) | ||||
| III (67) | 1 (1) | 30 (45) | 26 (39) | 1 (1) | 1 (1) | 2 (3) | 6 (9) |
| IV (2) | 2 (100) | ||||||
| V (26) | 1 (4) | 25 (96) | |||||
| NT (1) | 1 (100) | ||||||
| Sequence type | |||||||
| 1 (22) | 22 (100) | ||||||
| 8 (8) | 1 (13) | 1 (13) | 3 (38) | 2 (25) | 1 (13) | ||
| 10 (5) | 1 (20) | 2 (40) | 2 (40) | ||||
| 12 (5) | 1 (20) | 2 (40) | 1 (20) | 1 (20) | |||
| 17 (49) | 1 (2) | 17 (35) | 24 (49) | 2 (4) | 5 (10) | ||
| 19 (10) | 10 (100) | ||||||
| 23 (22) | 4 (18) | 6 (27) | 4 (18) | 5 (23) | 3 (14) | ||
| Others (21) | 3 (14) | 3 (14) | 10 (48) | 2 (10) | 3 (14) | ||
| Clonal complex | |||||||
| 1 (28) | 28 (100) | ||||||
| 7 (5) | 1 (20) | 1 (20) | 2 (40) | 1 (20) | |||
| 8 (18) | 1 (6) | 3 (17) | 7 (39) | 3 (17) | 1 (6) | 3 (17) | |
| 17 (51) | 1 (2) | 17 (33) | 26 (51) | 2 (4) | 5 (10) | ||
| 19 (11) | 11 (100) | ||||||
| 23 (24) | 5 (21) | 6 (25) | 5 (21) | 5 (21) | 3 (13) | ||
| Others (5) | 2 (40) | 1 (20) | 2 (40) | ||||
NP no prophage amplification; NT, nontypable.